Abstract
AIM: To detect the influence of major peptide β-casomorphin-7 (β-CM7) from milk on the absorption of glucose, and its mechanism in the diet and healthy food.
METHODS: In this study healthy adult SD rats were divided into control group (0 mol/L β-CM7), low-dose group (7.5 × 10-7mol/L β-CM7), middle-dose group (7.5 × 10-6 mol/L β-CM7) and high-dose group (7.5 × 10-5 mol/L β-CM7). Reverted sacs of adult rats in vitro were performed which were dipped into culture sample including β-CM7 and glucose and we designed a few tests: (1) the concentration of glucose in reverted sacs was detected using oxidase method of glucose; (2) the activity of Na+-K+-ATPase in small intestinal mucosa was observed with colorimetric method; (3) the mRNA expressions of sodium-glucose transporter (SGLT-1) and facilitative glucose transporter (GLUT-2) in small intestinal mucosa were analyzed using the Real-time PCR.
RESULTS: Compared with control group, β-CM7 of 7.5 × 10-7-7.5 × 10-5 mol/L significantly induced glucose concentration in vitro(1.09, 1.24, 1.12 vs 1.74, P = 0.01, 0.04, 0.02); the activity of Na+-K+-ATPase was reduced (85.73, 112.06, 109.68 vs 114.93, P = 0.004, 0.73, 0.54); the mRNA expressions of SGLT-1 and GLUT-2 were also significantly reduced (0.77, 0.58, 0.46 vs 1.11, P = 0.20, 0.05, 0.02; 0.50, 0.66, 0.85 vs 1.14, P = 0.30, 0.14, 0.03), compared with control group.
CONCLUSION: The present data demonstrated that β-CM7 was able to reduce the absorption of glucose through inhibiting activity of Na+-K+-ATPase and the mRNA expression level of SGLT-1, GLUT-2 in small intestine of rats.
Collapse